of information from Pneumo MD #10 (GOLD 2026, Part II.) on COPD exacerbation: The goal is to prevent COPD exacerbations and treat them properly. GOLD (Global Initiative for Chronic Obstructive Lung Disease) provides the tools to achieve this goal. It is important to differentiate a COPD exacerbation from other causes of dyspnea. The severity of the exacerbation is evaluated according to the new criteria (Rome proposal) based on measurable entry criteria. This classification helps determine where and how the exacerbation will be treated. Intravenous methylxanthines (theophylline, aminophylline) are not recommended due to significant adverse effects. At the beginning of the treatment, bronchodilators (SABA with/without SAMA) are given in the form of MDI through a spacer or by nebulization.